busulfan has been researched along with Kaposi Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagasawa, M | 1 |
| Itoh, S | 1 |
| Sawada, Y | 1 |
| Morio, T | 1 |
| Nonoyama, S | 1 |
| Mizutani, S | 1 |
| Roszkiewicz, A | 1 |
| Roszkiewicz, J | 1 |
| Lange, M | 1 |
| Tukaj, C | 1 |
2 other studies available for busulfan and Kaposi Sarcoma
| Article | Year |
|---|---|
Coagulopathy in a patient with X-linked hyper-IgM syndrome who developed Kaposi's sarcoma.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Chromos | 2004 |
Kaposi's sarcoma following long-term immunosuppressive therapy: clinical, histologic, and ultrastructural study.
Topics: Aged; Busulfan; CD4-CD8 Ratio; Diagnosis, Differential; Fatal Outcome; Humans; Immunocompromised Hos | 1998 |